α-Synuclein increases U251 cells vulnerability to hydrogen peroxide by disrupting calcium homeostasis

Journal of Neural Transmission

Volumn 118, Issue 8, 2011, Pages 1165-1172

  Ying, Zhengxin ^a   Lin, Fankai ^a   Gu, Weihong ^b   Su, Yang ^a   Arshad, Abida ^a   Qing, Hong ^a   Deng, Yulin ^a  

^a BEIJING INSTITUTE OF TECHNOLOGY   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Synuclein; Calcium; Calcium channels; Multiple system atrophy

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; ALPHA SYNUCLEIN; CALCIUM ION; HYDROGEN PEROXIDE; NIMODIPINE;

ARTICLE; CALCIUM HOMEOSTASIS; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; FLUOROMETRY; GLIA CELL; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHY DRAGER SYNDROME;

ALPHA-SYNUCLEIN; CALCIUM; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HOMEOSTASIS; HUMANS; HYDROGEN PEROXIDE;

EID: 80051595745     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0596-7     Document Type: Article

References (34)

1. A Adamczyk JB Strosznajder 2006 Alpha-synuclein potentiates Ca2+ influx through voltage-dependent Ca2+ channels Neuroreport 17 18 1883 1886 17179863 10.1097/WNR.0b013e3280115185 1:CAS:528:DC%2BD28XhtlansrvF (Pubitemid 46006291)
2. P Brundin J Karlsson, et al. 2000 Improving the survival of grafted dopaminergic neurons: A review over current approaches Cell Transplant 9 2 179 195 10811392 1:STN:280:DC%2BD3czosVOmsg%3D%3D (Pubitemid 30252685)
3. JD Cahoy B Emery, et al. 2008 A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function J Neurosci 28 1 264 278 18171944 10.1523/JNEUROSCI. 4178-07.2008 1:CAS:528:DC%2BD1cXmtV2ltw%3D%3D
4. KM Danzer D Haasen, et al. 2007 Different species of alpha-synuclein oligomers induce calcium influx and seeding J Neurosci 27 34 9220 9232 17715357 10.1523/JNEUROSCI.2617-07.2007 1:CAS:528:DC%2BD2sXhtVSnsLfM (Pubitemid 47312071)
5. W Droge 2002 Free radicals in the physiological control of cell function Physiol Rev 82 1 47 95 11773609 1:CAS:528:DC%2BD38XovFSisw%3D%3D (Pubitemid 34654215)
6. MM Fan LA Raymond 2007 N-methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease Prog Neurobiol 81 5-6 272 293 17188796 10.1016/j.pneurobio.2006.11.003 1:CAS:528:DC%2BD2sXjvFGqtLw%3D (Pubitemid 46528641)
7. DL Fortin VM Nemani, et al. 2005 Neural activity controls the synaptic accumulation of alpha-synuclein J Neurosci 25 47 10913 10921 16306404 10.1523/JNEUROSCI.2922-05.2005 1:CAS:528:DC%2BD2MXht1yks7%2FP (Pubitemid 41692621)
8. K Furukawa M Matsuzaki-Kobayashi, et al. 2006 Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells J Neurochem 97 4 1071 1077 16606366 10.1111/j.1471-4159.2006. 03803.x 1:CAS:528:DC%2BD28XlsVOnt78%3D
9. JE Galvin VM Lee, et al. 2001 Synucleinopathies: clinical and pathological implications Arch Neurol 58 2 186 190 11176955 10.1001/archneur.58. 2.186 1:STN:280:DC%2BD3M7ntFWlsQ%3D%3D (Pubitemid 32163154)
10. KN Green FM LaFerla 2008 Linking calcium to Abeta and Alzheimer's disease Neuron 59 2 190 194 18667147 10.1016/j.neuron.2008.07.013 1:CAS:528: DC%2BD1cXpsFOgtro%3D (Pubitemid 352033693)
11. NT Hettiarachchi A Parker, et al. 2009 Alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells J Neurochem 111 5 1192 1201 19860837 10.1111/j.1471-4159.2009.06411.x 1:CAS:528:DC%2BD1MXhsVyrsbfK
12. R Jakes MG Spillantini, et al. 1994 Identification of two distinct synucleins from human brain FEBS Lett 345 1 27 32 8194594 10.1016/0014-5793(94) 00395-5 1:CAS:528:DyaK2cXlslehtb4%3D (Pubitemid 24154659)
13. KE Larsen Y Schmitz, et al. 2006 Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis J Neurosci 26 46 11915 11922 17108165 10.1523/JNEUROSCI.3821- 06.2006 1:CAS:528:DC%2BD28Xht1ylu7bJ (Pubitemid 44772102)
14. MK Lee W Stirling, et al. 2002 Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice Proc Natl Acad Sci USA 99 13 8968 8973 12084935 10.1073/pnas.132197599 1:CAS:528: DC%2BD38XltF2htbk%3D (Pubitemid 34693667)
15. MP Mattson 2007 Calcium and neurodegeneration Aging Cell 6 3 337 350 17328689 10.1111/j.1474-9726.2007.00275.x 1:CAS:528:DC%2BD2sXntVOjsr4%3D (Pubitemid 46785139)
16. EV Mosharov KE Larsen, et al. 2009 Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons Neuron 62 2 218 229 19409267 10.1016/j.neuron.2009.01.033 1:CAS:528: DC%2BD1MXlvFSrtrs%3D
17. VM Nemani W Lu, et al. 2010 Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis Neuron 65 1 66 79 20152114 10.1016/j.neuron.2009.12.023 1:CAS:528:DC%2BC3cXlt1KmsLw%3D
18. S Orrenius B Zhivotovsky, et al. 2003 Regulation of cell death: the calcium-apoptosis link Nat Rev Mol Cell Biol 4 7 552 565 12838338 10.1038/nrm1150 1:CAS:528:DC%2BD3sXltVWnu7g%3D (Pubitemid 36773407)
19. MI Papp JE Kahn, et al. 1989 Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) J Neurol Sci 94 1-3 79 100 2559165 10.1016/0022-510X(89)90219-0 1:STN:280:DyaK3c7jt1OrtA%3D%3D (Pubitemid 20019446)
20. CW Shults E Rockenstein, et al. 2005 Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy J Neurosci 25 46 10689 10699 16291942 10.1523/JNEUROSCI.3527-05.2005 1:CAS:528: DC%2BD2MXht1KqsbzP (Pubitemid 41681917)
21. JH Soper S Roy, et al. 2008 Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae Mol Biol Cell 19 3 1093 1103 18172022 10.1091/mbc.E07-08-0827 1:CAS:528:DC%2BD1cXlslemsLs%3D (Pubitemid 351481822)
22. CG Specht CM Tigaret, et al. 2005 Subcellular localisation of recombinant alpha- and gamma-synuclein Mol Cell Neurosci 28 2 326 334 15691713 10.1016/j.mcn.2004.09.017 1:CAS:528:DC%2BD2MXhtVOmur0%3D (Pubitemid 40202593)
23. N Stefanova L Klimaschewski, et al. 2001 Glial cell death induced by overexpression of alpha-synuclein J Neurosci Res 65 5 432 438 11536327 10.1002/jnr.1171 1:CAS:528:DC%2BD3MXmvFWgs7k%3D (Pubitemid 32831396)
24. N Stefanova M Reindl, et al. 2005 Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy Am J Pathol 166 3 869 876 15743798 10.1016/S0002-9440(10)62307-3 1:CAS:528:DC%2BD2MXivVOmsb0%3D (Pubitemid 40315643)
25. N Stefanova M Reindl, et al. 2005 In vitro models of multiple system atrophy Mov Disord 20 Suppl 12 S53 S56 16092091 10.1002/mds.20540 (Pubitemid 41419555)
26. DJ Surmeier 2007 Calcium, ageing, and neuronal vulnerability in Parkinson's disease Lancet Neurol 6 10 933 938 17884683 10.1016/S1474-4422(07) 70246-6 1:CAS:528:DC%2BD2sXht1Krtr%2FN (Pubitemid 47405004)
27. PH Tu JE Galvin, et al. 1998 Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein Ann Neurol 44 3 415 422 9749615 10.1002/ana.410440324 1:CAS:528:DyaK1cXmtFKls7w%3D (Pubitemid 28421453)
28. MJ Volles PT Lansbury Jr 2003 Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease Biochemistry 42 26 7871 7878 12834338 10.1021/bi030086j 1:CAS:528: DC%2BD3sXktlWrtrg%3D (Pubitemid 36807703)
29. F von Lewinski BU Keller 2005 Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS Trends Neurosci 28 9 494 500 10.1016/j.tins.2005.07.001 (Pubitemid 41187799)
30. K Wakabayashi M Yoshimoto, et al. 1998 Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy Neurosci Lett 249 2-3 180 182 9682846 10.1016/S0304-3940(98)00407-8 1:CAS:528:DyaK1cXjvVWisLg%3D (Pubitemid 28331545)
31. GK Wenning KA Jellinger 2005 The role of alpha-synuclein in the pathogenesis of multiple system atrophy Acta Neuropathol 109 2 129 140 15666181 10.1007/s00401-004-0935-y 1:CAS:528:DC%2BD2MXis1Oktb0%3D (Pubitemid 40468383)
32. GK Wenning N Stefanova, et al. 2008 Multiple system atrophy: A primary oligodendrogliopathy Ann Neurol 64 3 239 246 18825660 10.1002/ana.21465 1:CAS:528:DC%2BD1cXht1yisrzF
33. I Yazawa BI Giasson, et al. 2005 Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration Neuron 45 6 847 859 15797547 10.1016/j.neuron.2005.01.032 1:CAS:528:DC%2BD2MXjt1Oitb4%3D (Pubitemid 40395264)
34. W Zhou J Schaack, et al. 2002 Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture Brain Res 926 1-2 42 50 11814405 10.1016/S0006-8993(01)03292-9 1:CAS:528: DC%2BD38Xos1Kiuw%3D%3D (Pubitemid 34117588)